The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy

Diabetes is a major cause of visual impairment among workingage adults in the United States. The proliferative form of diabetic retinopathy is associated with severe vision loss (acuity <5/200). The standard treatment in proliferative diabetic retinopathy (PDR) is panretinal photocoagulation (PRP...

Full description

Bibliographic Details
Main Authors: Yue Zhao, Rishi P Singh
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2018-08-01
Series:Drugs in Context
Subjects:
aflibercept
angiogenesis inhibitors
antibodies
monoclonal
humanized antibodies
bevacizumab
diabetic retinopathy
intravitreal injection
ranibizumab
vascular endothelial growth factor A
Online Access:https://www.drugsincontext.com/the-role-of-anti-vascular-endothelial-growth-factor-anti-vegf-in-the-management-of-proliferative-diabetic-retinopathy

Internet

https://www.drugsincontext.com/the-role-of-anti-vascular-endothelial-growth-factor-anti-vegf-in-the-management-of-proliferative-diabetic-retinopathy

Similar Items